MedPath

Evluation of clinical trial for the rapid diagnostic kit of norovirus

Not Applicable
Conditions
orovirus
Registration Number
JPRN-UMIN000020102
Lead Sponsor
EIKEN CHEMICAL Co., Ltd.
Brief Summary

As compared to RT-PCR, the sensitivity, secificity and concordance rate is 79.3% (169/213), 99.4%(357/359) and 92.0% (526/572), respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

The patient applicable to the following items 1)The patient who has participated in other clinical trials 2)The patient judged to be unsuitable by the doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity, specificity and concordance rate in comparison with the RT-PCR method
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath